Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Top Page
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
(2502)
Select Model
Select Model
Rating:52Neutral
Price Target:
HK$0.49
▲(13.95% Upside)
Action:ReiteratedDate:03/26/26
The score is held back primarily by weakened financial performance, with a swing to losses and margin compression despite stable leverage and positive operating cash flow. Technicals provide support as price is trending above key moving averages with neutral-to-positive momentum. Valuation remains a drawback because earnings are negative and dividend yield data is unavailable.
Positive Factors
Consistent operating cash flow
Sustained positive operating cash flow provides durable internal liquidity to fund working capital, capex and restructuring without immediate external financing. Over 2–6 months this underpins operational resilience and gives management flexibility to stabilize margins and invest selectively.
Negative Factors
Revenue contraction
Material revenue decline signals weakening demand or loss of pricing/volume, reducing scale economics and limiting room to recover margins. Persistent top-line shrinkage over multiple quarters will stress cash flow and complicate restoration of prior profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent operating cash flow
Sustained positive operating cash flow provides durable internal liquidity to fund working capital, capex and restructuring without immediate external financing. Over 2–6 months this underpins operational resilience and gives management flexibility to stabilize margins and invest selectively.
Read all positive factors
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$811.10M
Dividend YieldN/A
Average Volume (3M)143.80K
Price to Earnings (P/E)―
Beta (1Y)0.26
Revenue Growth2.76%
EPS Growth-293.57%
CountryHK
Employees402
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.02
Shares Outstanding955,640,000
10 Day Avg. Volume251,400
30 Day Avg. Volume143,800
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)0.39
Price to Sales (P/S)0.15
P/FCF Ratio5.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People's Republic of China. Its hydrogenated benzene-based chemicals in...
How the Company Makes Money
null...
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
54
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.53B | 3.10B | 2.33B | 2.30B | 1.48B |
| Gross Profit | 30.08M | 71.64M | 148.80M | 285.51M | 142.80M |
| EBITDA | 92.32M | 77.03M | 163.47M | 294.84M | 168.50M |
| Net Income | -33.39M | -16.04M | 54.92M | 138.23M | 72.47M |
Balance Sheet | |||||
| Total Assets | 1.52B | 1.68B | 1.66B | 1.08B | 971.94M |
| Cash, Cash Equivalents and Short-Term Investments | 357.55M | 352.62M | 300.71M | 92.47M | 50.08M |
| Total Debt | 290.06M | 338.27M | 262.97M | 165.30M | 51.17M |
| Total Liabilities | 446.60M | 584.85M | 535.95M | 355.88M | 418.55M |
| Stockholders Equity | 951.54M | 985.37M | 1.02B | 573.79M | 457.93M |
Cash Flow | |||||
| Free Cash Flow | 72.66M | 13.82M | -43.95M | 199.74M | 44.27M |
| Operating Cash Flow | 114.76M | 96.86M | 104.46M | 318.82M | 94.88M |
| Investing Cash Flow | -41.12M | -268.86M | -71.06M | -150.12M | -58.70M |
| Financing Cash Flow | -68.09M | 2.49M | 204.95M | -139.06M | -44.28M |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis
Neutral
0.43
Price Trends
0.48
Negative
0.46
Positive
0.45
Positive
Market Momentum
<0.01
Positive
44.13
Neutral
13.13
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Neutral. The current price of 0.43 is below the 20-day moving average (MA) of 0.55, below the 50-day MA of 0.48, and below the 200-day MA of 0.45, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.13 is Neutral, neither overbought nor oversold. The STOCH value of 13.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2502.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$1.26B | 7.76 | 3.36% | 7.85% | -5.37% | 25.20% | |
64 Neutral | HK$340.80M | 14.38 | 6.51% | 2.00% | 29.04% | -1.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | HK$809.06M | 20.68 | -1.56% | 5.55% | 0.37% | -331.54% | |
52 Neutral | HK$811.10M | -11.05 | -3.55% | ― | 2.76% | -293.57% | |
48 Neutral | HK$705.69M | -19.22 | -15.41% | ― | 0.35% | -153.95% | |
48 Neutral | HK$58.47M | -0.06 | ― | ― | -15.10% | 31.07% |
* Basic Materials Sector Average
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.49
0.20
67.24%
HK:0408
Yip's Chemical Holdings
2.24
0.96
75.41%
HK:1986
Tsaker New Energy Tech Co., Limited
0.84
0.23
37.70%
HK:2116
Jiangsu Innovative Ecological New Materials Ltd.
0.71
0.25
54.35%
HK:0301
SANVO Fine Chemicals Group Limited
1.50
0.73
94.81%
HK:0377
China Huajun Group Limited
0.95
0.05
5.56%
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events
Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue
Mar 23, 2026
Henan Jinyuan Hydrogenated Chemicals reported 2025 revenue of RMB2.60 billion, down from RMB3.10 billion a year earlier, as gross profit narrowed sharply and joint-venture performance turned negative. The group swung to a net loss attributable to ...
Henan Jinyuan Flags Wider 2025 Loss on Higher Costs and LNG Margin Squeeze
Mar 16, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has warned that it expects to post a loss of about RMB34.2 million attributable to shareholders for 2025, widening from a loss of roughly RMB15.8 million a year earlier. The company said the deteriora...
Henan Jinyuan Hydrogenated Chemicals Sets March Board Meeting on 2025 Results and Dividend
Mar 9, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has scheduled a board meeting for 23 March 2026 to review and approve the audited annual results for the year ended 31 December 2025, with plans to publish the figures on both the Hong Kong stock exch...
Henan Jinyuan Hydrogenated Chemicals Sets Out Board and Committee Structure
Jan 30, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced the current composition of its board of directors, detailing the roles of executive, non-executive and independent non-executive directors, including the general manager, deputy general ...
Henan Jinyuan Hydrogenated Chemicals Overhauls Governance After EGM Resolutions Passed Unanimously
Jan 30, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported that shareholders approved all resolutions at its extraordinary general meeting on 30 January 2026 by poll, with 75% of issued H shares represented at the meeting and 100% of votes cast in fa...
Henan Jinyuan Hydrogenated Chemicals Calls January EGM to Approve New Director and Supervisor
Jan 8, 2026
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has convened an extraordinary general meeting for 30 January 2026 in Hong Kong to seek shareholder approval for board and supervisory committee changes. Shareholders will vote on the election and remu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.